fda drug safety communication naion semaglutide 2025 linked to increased risk of vision loss in diabetes patients Compounded "semaglutide" is not FDA-approved

But here is the critical context most supplement marketers leave out

Microdosing continues to be studied as a potential avenue to help with side effects and tolerance issues

Magnesium is one of the most important starting points

The FDA has approved these medications for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia

Increasing nutrient-dense foods such as fruits, vegetables, and lean meats, and limiting certain carbohydrates help obtain a calorie deficit needed to continue with weight loss

Disclaimer This article is for educational purposes only and is not a substitute for medical advice